HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 291/1/G102    most recent 00575.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Donahower, B. Articles by James, L. P. Search for Related Content PubMed PubMed Citation Articles by Donahower, B. Articles by James, L. P.

LIVER AND BILIARY TRACT

Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity

Departments of ¹Pharmacology, ²Pediatrics, ³Physiology and Biophysics, and ⁴Pathology, University of Arkansas for Medical Sciences and ⁵Arkansas Children's Hospital Research Institute, Little Rock, Arkansas

Submitted 20 December 2005 ; accepted in final form 20 March 2006

VEGF or VEGF-A is a major regulator of angiogenesis and has been recently shown to be important in organ repair. The potential role of VEGF in acetaminophen (APAP)-induced hepatotoxicity and recovery was investigated in B6C3F1 male mice. Mice were treated with APAP (300 mg/kg ip) and killed at various time points that reflect both the acute and recovery stages of toxicity. VEGF-A protein levels were increased 7-fold at 8 h and followed the development of hepatotoxicity. VEGF receptor 1, 2, and 3 (VEGFR1, VEGFR2, and VEGFR3, respectively) expression increased throughout the time course, with maximal expression at 48, 8, and 72 h, respectively. Treatment with the VEGF receptor inhibitor SU5416 (25 mg/kg ip at 3 h) had no effect on toxicity at 6 or 24 h. In further studies, the role of SU5416 on the late stages of toxicity was examined. Treatment of mice with APAP and SU5416 (25 mg/kg ip at 3 h) resulted in decreased expression of PCNA, a marker of cellular proliferation. Expression of platelet endothelial cell adhesion molecule, a measure of small vessel density, and endothelial nitric oxide synthase (NOS), a downstream target of VEGFR2, were increased at 48 and 72 h following toxic doses of APAP, and treatment with SU5416 decreased their expression. These data indicate that endogenous VEGF is critically important to the process of hepatocyte regeneration in APAP-induced hepatotoxicity in the mouse.

angiogenesis; liver injury; liver repair

This article has been cited by other articles:

				M. L. Bajt, H.-M. Yan, A. Farhood, and H. Jaeschke Plasminogen Activator Inhibitor-1 Limits Liver Injury and Facilitates Regeneration after Acetaminophen Overdose Toxicol. Sci., August 1, 2008; 104(2): 419 - 427. [Abstract] [Full Text] [PDF]

				G. Van Buren II, A. D. Yang, N. A. Dallas, M. J. Gray, S. J. Lim, L. Xia, F. Fan, R. Somcio, Y. Wu, D. J. Hicklin, et al. Effect of Molecular Therapeutics on Liver Regeneration in a Murine Model J. Clin. Oncol., April 10, 2008; 26(11): 1836 - 1842. [Abstract] [Full Text] [PDF]